Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Patent
1994-12-30
1998-06-16
Loring, Susan A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
4242771, 4241851, 530300, 530380, 530381, 530382, 530350, A61K 3900, C07K 700, C07K 14705, C07K 14745
Patent
active
057665915
ABSTRACT:
The present invention describes methods for inhibiting angiogenesis in tissues using vitronectin .alpha..sub.v .beta..sub.3 antagonists, and particularly for inhibiting angiogenesis in inflamed tissues and in tumor tissues and metastases using therapeutic compositions containing .alpha..sub.v .beta..sub.3 antagonists.
REFERENCES:
patent: 5092885 (1992-03-01), Yamada et al.
patent: 5112946 (1992-05-01), Maione et al.
patent: 5192744 (1993-03-01), Bouck et al.
patent: 5202352 (1993-04-01), Okada et al.
Cheresh, D.A. et al, Cell, 58:945-953, Sep. 8, 1989.
Folkman et al., Science, 235:442-447, 23 Jan. 1987.
Jackson, C. J. et al., Annals of the Rheumatic Diseases, 48:733-736, 1989.
Gurrath, M. et al, Eur J. Biochem, 210:911-921, 1992.
Davis, et al., "Identification of a Role of the Vitronectin Receptor and Protein Kinase C in the Induction of Endothelial Cell Vascular Formation", J. Cell. Biochem., 51: 206-218 (1993).
Folkman, et al., "Angiogenic Factors", Science, 235: 442-447 (1987).
Moses, et al., "Identification of an Inhibitor of Neovascularization from Cartilage", Science, 248: 1408-1410 (1990).
Folkman, et al., "Inhibition of Angiogenesis", Cancer Biology, 3: 89-96 (1992).
Blood, et al., "Tumor Interactions with the Vasculature: Angiogenesis and Tumor Metastasis", Bioch. Biophys. Acta., 1032: 89-118 (1990).
Ingber, et al., "Inhibition of Angiogenesis Through Modulation of Collagen Metabolism", Lab. Invest., 59: 44-51 (1988).
Aumailley, et al., "Arg-Gly-Asp Constrained within Cyclic Pentapeptides", FEBS Letts., 291: 50-54 (1991).
Choi, et al., "Inhibition of Neointimal Hyperplasia by Blocking .alpha.v.beta.3 Integrin With a Small Peptide Antagonist GpenGRGDSPCA", J. Vasc. Surg., 19: 125-134 (1994).
Smith, et al., "Interaction of Integrins .alpha.v.beta.3 and Glycoprotein IIb-IIIa with Fibrinogen", J. Biol. Chem., 265: 12267-12271.
Nicosia, et al., "Inhibition of Angiogensis In Vitro by Arg-Gly-Asp-Containing Synthetic Peptide", Am. J. Pathol., 138: 829-833 (1991).
Cheresh, et al., "Biosynthetic and Functional Properties of an Arg-Gly-Asp-directed Receptor Involved in Human Melanoma Cell Attachment to Vitronectin, Fibrinogen and von Willebrand Factor", J. Biol. Chem., 262: 17703-17711 (1987).
Leavesley, et al., "Integrin .beta.1-and .beta.3-mediated Endothelial Cell Migration is Triggered Through Distinct Signaling Mechanisms", J. Cell Biol., 121: 163-170 (1993).
Swerlick, et al., "Expression and Modulation of the Vitronectin Receptor on Human Dermal Microvascular Endothelial Cells", J. Invest. Derm., 99: 715-722 (1992).
Brooks, et al., "Subtractive Immunization Yields Monoclonal Antibodies that Specifically Inhibit Metastasis", J. Cell Biol., 122: 1351-1359 (1993).
Ausprunk, et al., Am. J. Pathol., 79:597-618 (1975).
Cheresh, et al., Cell, 58:945-953 (1989).
D'Amato, et al., Proc. Natl. Acad. Sci., 91:4082-4085 (1994).
Folkman, et al., Sem. Cancer Biol., 3:89-96 (1992).
Gavrieli, et al., J. Cell Biol., 119:493-501 (1992).
Leibovich, et al., Nature, 329:630 (1987).
Ossonski, et al., Cancer Res., 40:2300-2309 (1980).
Pfaff, et al., J. Biol. Chem., 269:20233-20238, 1994.
Yan, et al., J. Clin. Invest., 91:986-996 (1993).
Folkman, J. and Ingber, D., "Inhibition of Angiogenesis", Cancer Biology, 3:89-96 (1992).
Brooks Peter
Cheresh David A.
Fitting Thomas
Holmes Emily
Loring Susan A.
The Scripps Research Institute
LandOfFree
Methods and compositions useful for inhibition of angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions useful for inhibition of angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions useful for inhibition of angiogenesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1721867